+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies



Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies



Journal of Affective Disorders 197: 9-20



The neurotrophin hypothesis of major depressive disorder (MDD) postulates that this illness results from aberrant neurogenesis in brain regions that regulates emotion and memory. Notwithstanding this theory has primarily implicated BDNF in the neurobiology of MDD. Recent evidence suggests that other trophic factors namely GDNF, VEGF and IGF-1 may also be involved. The present review aimed to critically summarize evidence regarding changes in GDNF, IGF-1 and VEGF in individuals with MDD compared to healthy controls. In addition, we also evaluated the role of these mediators as potential treatment response biomarkers for MDD. A comprehensive review of original studies studies measuring peripheral, central or mRNA levels of GDNF, IGF-1 or VEGF in patients with MDD was conducted. The PubMed/MEDLINE database was searched for peer-reviewed studies published in English through June 2nd, 2015. Most studies reported a reduction in peripheral GDNF and its mRNA levels in MDD patients versus controls. In contrast, IGF-1 levels in MDD patients compared to controls were discrepant across studies. Finally, most studies reported high peripheral VEGF levels and mRNA expression in MDD patients compared to healthy controls. GDNF, IGF-1 and VEGF levels and their mRNA expression appear to be differentially altered in MDD patients compared to healthy individuals, indicating that these molecules might play an important role in the pathophysiology of depression and antidepressant action of therapeutic interventions.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791670

Download citation: RISBibTeXText

PMID: 26956384

DOI: 10.1016/j.jad.2016.02.067


Related references

The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review. Current Neuropharmacology 14(2): 191-199, 2016

Does refining the phenotype improve replication rates? A review and replication of candidate gene studies on Major Depressive Disorder and Chronic Major Depressive Disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 171b(2): 215-236, 2016

The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Current Medical Research and Opinion 24(8): 2359-2371, 2008

The role of genes and environment on brain alterations in Major Depressive Disorder: A review of twin studies. Journal of Affective Disorders, 2017

A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder. Cns and Neurological Disorders Drug Targets 15(1): 35-44, 2016

Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature. Neuropsychiatrie 28(2): 74-83, 2014

A comprehensive review of genetic and epigenetic mechanisms that regulate BDNF expression and function with relevance to major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 177(2): 143-167, 2017

Neuropsychological profiles of major depressive disorder and bipolar disorder during euthymia. A systematic literature review of comparative studies. Psychiatry Research 248: 127-133, 2017

A review of the role of social cognition in major depressive disorder. Frontiers in Psychiatry 5: 179, 2015

Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex in depressive episodes of patients with major depressive disorder, bipolar disorder I, and major depressive with alcohol use disorders. Neuroscience Letters 671: 128-132, 2018

Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder. Psychiatry Investigation 15(8): 818-823, 2018

A review of factors that moderate autobiographical memory performance in patients with major depressive disorder. Journal of Clinical and Experimental Neuropsychology 32(10): 1122-1144, 2011

Dementia, post-traumatic stress disorder and major depressive disorder: a review of the mental health risk factors for dementia in the military veteran population. Psychological Medicine 48(9): 1400-1409, 2018

Neuroimaging genomic studies in major depressive disorder: A systematic review. Cns Neuroscience and Therapeutics 24(11): 1020-1036, 2018

Does emotion predict the course of major depressive disorder? A review of prospective studies. British Journal of Clinical Psychology 48(Pt 3): 255-273, 2009